APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cefotaxime Sodium API

Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.

Selected research

Industry Growth & Trends

Global Cefotaxime Sodium API Industry Growth and Trends Forecast to 2032

26 December 2025112 pages

Choose your research edition.

Industry ResearchCefotaxime Sodium API Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Cefotaxime Sodium API Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cefotaxime Sodium API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cefotaxime Sodium API Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cefotaxime Sodium API Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.

Market competition is intense. REYOUNG, Nectar Lifesciences, Medya Pharma, Sandoz, Kelun, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accountted for 57.98% market share in 2019.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Cefotaxime Sodium API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cefotaxime Sodium API market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cefotaxime Sodium API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cefotaxime Sodium API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cefotaxime Sodium API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cefotaxime Sodium API Market by Company

REYOUNG

Nectar Lifesciences

Medya Pharma

Sandoz

Kelun

NCPC

Aurobindo Pharma

United Laboratories

Orchid Pharma

CSPC

Kopran

Covalent

ACS Dobfar

Dawnrays

Sterile India

Cefotaxime Sodium API Segment by Type

ChP

USP

EP

Cefotaxime Sodium API Segment by Application

Single Injection

Compound Injection

Cefotaxime Sodium API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefotaxime Sodium API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cefotaxime Sodium API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefotaxime Sodium API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cefotaxime Sodium API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cefotaxime Sodium API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ChP Table 2. Major Company of USP Table 3. Major Company of EP Table 4. Global Cefotaxime Sodium API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cefotaxime Sodium API Sales by Type (2021-2026) & (MT) Table 6. Global Cefotaxime Sodium API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cefotaxime Sodium API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cefotaxime Sodium API Sales Market Share in Value by Type (2021-2026) Table 9. Global Cefotaxime Sodium API Price by Type (2021-2026) & (USD/MT) Table 10. Global Cefotaxime Sodium API Sales by Type (2027-2032) & (MT) Table 11. Global Cefotaxime Sodium API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cefotaxime Sodium API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cefotaxime Sodium API Sales Market Share in Value by Type (2027-2032) Table 14. Global Cefotaxime Sodium API Price by Type (2027-2032) & (USD/MT) Table 15. North America Cefotaxime Sodium API Sales by Type (2021-2026) & (MT) Table 16. North America Cefotaxime Sodium API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cefotaxime Sodium API Sales by Type (2021-2026) & (MT) Table 18. Europe Cefotaxime Sodium API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cefotaxime Sodium API Sales by Type (2021-2026) & (MT) Table 20. Asia-Pacific Cefotaxime Sodium API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cefotaxime Sodium API Sales by Type (2021-2026) & (MT) Table 22. Latin America Cefotaxime Sodium API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cefotaxime Sodium API Sales by Type (2021-2026) & (MT) Table 24. Middle East and Africa Cefotaxime Sodium API Sales by Type (2021-2026) & (US$ Million) Table 25. Cefotaxime Sodium API Industry Trends Table 26. Cefotaxime Sodium API Industry Drivers Table 27. Cefotaxime Sodium API Industry Opportunities and Challenges Table 28. Cefotaxime Sodium API Industry Restraints Table 29. Global Cefotaxime Sodium API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cefotaxime Sodium API Revenue Market Share by Company (2021-2026) Table 31. Global Cefotaxime Sodium API Sales by Company (2021-2026) & (MT) Table 32. Global Cefotaxime Sodium API Sales Share by Company (2021-2026) Table 33. Global Cefotaxime Sodium API Market Price by Company (2021-2026) & (USD/MT) Table 34. Global Cefotaxime Sodium API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cefotaxime Sodium API Major Company Production Sites and Headquarters Table 36. Global Cefotaxime Sodium API Company, Product Type & Application Table 37. Global Cefotaxime Sodium API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cefotaxime Sodium API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cefotaxime Sodium API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cefotaxime Sodium API Sales by Region (2021-2026) & (MT) Table 42. Global Cefotaxime Sodium API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cefotaxime Sodium API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cefotaxime Sodium API Sales Market Share in Value by Region (2021-2026) Table 45. Global Cefotaxime Sodium API Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 46. Global Cefotaxime Sodium API Sales by Region (2027-2032) & (MT) Table 47. Global Cefotaxime Sodium API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cefotaxime Sodium API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cefotaxime Sodium API Sales Market Share in Value by Region (2027-2032) Table 50. Global Cefotaxime Sodium API Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 51. Global Cefotaxime Sodium API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cefotaxime Sodium API Sales by Application (2021-2026) & (MT) Table 53. Global Cefotaxime Sodium API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cefotaxime Sodium API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cefotaxime Sodium API Sales Market Share in Value by Application (2021-2026) Table 56. Global Cefotaxime Sodium API Price by Application (2021-2026) & (USD/MT) Table 57. Global Cefotaxime Sodium API Sales by Application (2027-2032) & (MT) Table 58. Global Cefotaxime Sodium API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cefotaxime Sodium API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cefotaxime Sodium API Sales Market Share in Value by Application (2027-2032) Table 61. Global Cefotaxime Sodium API Price by Application (2027-2032) & (USD/MT) Table 62. North America Cefotaxime Sodium API Sales by Application (2021-2026) & (MT) Table 63. North America Cefotaxime Sodium API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cefotaxime Sodium API Sales by Application (2021-2026) & (MT) Table 65. Europe Cefotaxime Sodium API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cefotaxime Sodium API Sales by Application (2021-2026) & (MT) Table 67. Asia-Pacific Cefotaxime Sodium API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cefotaxime Sodium API Sales by Application (2021-2026) & (MT) Table 69. Latin America Cefotaxime Sodium API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cefotaxime Sodium API Sales by Application (2021-2026) & (MT) Table 71. Middle East and Africa Cefotaxime Sodium API Sales by Application (2021-2026) & (US$ Million) Table 72. REYOUNG Company Information Table 73. REYOUNG Business Overview Table 74. REYOUNG Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 75. REYOUNG Cefotaxime Sodium API Product Portfolio Table 76. REYOUNG Recent Development Table 77. Nectar Lifesciences Company Information Table 78. Nectar Lifesciences Business Overview Table 79. Nectar Lifesciences Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 80. Nectar Lifesciences Cefotaxime Sodium API Product Portfolio Table 81. Nectar Lifesciences Recent Development Table 82. Medya Pharma Company Information Table 83. Medya Pharma Business Overview Table 84. Medya Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 85. Medya Pharma Cefotaxime Sodium API Product Portfolio Table 86. Medya Pharma Recent Development Table 87. Sandoz Company Information Table 88. Sandoz Business Overview Table 89. Sandoz Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 90. Sandoz Cefotaxime Sodium API Product Portfolio Table 91. Sandoz Recent Development Table 92. Kelun Company Information Table 93. Kelun Business Overview Table 94. Kelun Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 95. Kelun Cefotaxime Sodium API Product Portfolio Table 96. Kelun Recent Development Table 97. NCPC Company Information Table 98. NCPC Business Overview Table 99. NCPC Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 100. NCPC Cefotaxime Sodium API Product Portfolio Table 101. NCPC Recent Development Table 102. Aurobindo Pharma Company Information Table 103. Aurobindo Pharma Business Overview Table 104. Aurobindo Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 105. Aurobindo Pharma Cefotaxime Sodium API Product Portfolio Table 106. Aurobindo Pharma Recent Development Table 107. United Laboratories Company Information Table 108. United Laboratories Business Overview Table 109. United Laboratories Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 110. United Laboratories Cefotaxime Sodium API Product Portfolio Table 111. United Laboratories Recent Development Table 112. Orchid Pharma Company Information Table 113. Orchid Pharma Business Overview Table 114. Orchid Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 115. Orchid Pharma Cefotaxime Sodium API Product Portfolio Table 116. Orchid Pharma Recent Development Table 117. CSPC Company Information Table 118. CSPC Business Overview Table 119. CSPC Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 120. CSPC Cefotaxime Sodium API Product Portfolio Table 121. CSPC Recent Development Table 122. Kopran Company Information Table 123. Kopran Business Overview Table 124. Kopran Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 125. Kopran Cefotaxime Sodium API Product Portfolio Table 126. Kopran Recent Development Table 127. Covalent Company Information Table 128. Covalent Business Overview Table 129. Covalent Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 130. Covalent Cefotaxime Sodium API Product Portfolio Table 131. Covalent Recent Development Table 132. ACS Dobfar Company Information Table 133. ACS Dobfar Business Overview Table 134. ACS Dobfar Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 135. ACS Dobfar Cefotaxime Sodium API Product Portfolio Table 136. ACS Dobfar Recent Development Table 137. Dawnrays Company Information Table 138. Dawnrays Business Overview Table 139. Dawnrays Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 140. Dawnrays Cefotaxime Sodium API Product Portfolio Table 141. Dawnrays Recent Development Table 142. Sterile India Company Information Table 143. Sterile India Business Overview Table 144. Sterile India Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 145. Sterile India Cefotaxime Sodium API Product Portfolio Table 146. Sterile India Recent Development Table 147. North America Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 148. North America Cefotaxime Sodium API Sales by Country (2021-2026) & (MT) Table 149. North America Cefotaxime Sodium API Sales Market Share by Country (2021-2026) Table 150. North America Cefotaxime Sodium API Sales Forecast by Country (2027-2032) & (MT) Table 151. North America Cefotaxime Sodium API Sales Market Share Forecast by Country (2027-2032) Table 152. North America Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. North America Cefotaxime Sodium API Market Size by Country (2021-2026) & (US$ Million) Table 154. North America Cefotaxime Sodium API Market Share by Country (2021-2026) Table 155. North America Cefotaxime Sodium API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. North America Cefotaxime Sodium API Market Share Forecast by Country (2027-2032) Table 157. Europe Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 158. Europe Cefotaxime Sodium API Sales by Country (2021-2026) & (MT) Table 159. Europe Cefotaxime Sodium API Sales Market Share by Country (2021-2026) Table 160. Europe Cefotaxime Sodium API Sales Forecast by Country (2027-2032) & (MT) Table 161. Europe Cefotaxime Sodium API Sales Market Share Forecast by Country (2027-2032) Table 162. Europe Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Europe Cefotaxime Sodium API Market Size by Country (2021-2026) & (US$ Million) Table 164. Europe Cefotaxime Sodium API Market Share by Country (2021-2026) Table 165. Europe Cefotaxime Sodium API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Europe Cefotaxime Sodium API Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Cefotaxime Sodium API Sales by Country (2021-2026) & (MT) Table 169. Asia-Pacific Cefotaxime Sodium API Sales Market Share by Country (2021-2026) Table 170. Asia-Pacific Cefotaxime Sodium API Sales Forecast by Country (2027-2032) & (MT) Table 171. Asia-Pacific Cefotaxime Sodium API Sales Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Cefotaxime Sodium API Market Size by Country (2021-2026) & (US$ Million) Table 174. Asia-Pacific Cefotaxime Sodium API Market Share by Country (2021-2026) Table 175. Asia-Pacific Cefotaxime Sodium API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Asia-Pacific Cefotaxime Sodium API Market Share Forecast by Country (2027-2032) Table 177. Latin America Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 178. Latin America Cefotaxime Sodium API Sales by Country (2021-2026) & (MT) Table 179. Latin America Cefotaxime Sodium API Sales Market Share by Country (2021-2026) Table 180. Latin America Cefotaxime Sodium API Sales Forecast by Country (2027-2032) & (MT) Table 181. Latin America Cefotaxime Sodium API Sales Market Share Forecast by Country (2027-2032) Table 182. Latin America Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Latin America Cefotaxime Sodium API Market Size by Country (2021-2026) & (US$ Million) Table 184. Latin America Cefotaxime Sodium API Market Share by Country (2021-2026) Table 185. Latin America Cefotaxime Sodium API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Latin America Cefotaxime Sodium API Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Cefotaxime Sodium API Sales by Country (2021-2026) & (MT) Table 189. Middle East and Africa Cefotaxime Sodium API Sales Market Share by Country (2021-2026) Table 190. Middle East and Africa Cefotaxime Sodium API Sales Forecast by Country (2027-2032) & (MT) Table 191. Middle East and Africa Cefotaxime Sodium API Sales Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Cefotaxime Sodium API Market Size by Country (2021-2026) & (US$ Million) Table 194. Middle East and Africa Cefotaxime Sodium API Market Share by Country (2021-2026) Table 195. Middle East and Africa Cefotaxime Sodium API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Middle East and Africa Cefotaxime Sodium API Market Share Forecast by Country (2027-2032) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Cefotaxime Sodium API Distributors List Table 200. Cefotaxime Sodium API Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Cefotaxime Sodium API Image Figure 2. Global Cefotaxime Sodium API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cefotaxime Sodium API Market Size (2021-2032) & (US$ Million) Figure 4. Global Cefotaxime Sodium API Sales (2021-2032) & (MT) Figure 5. ChP Image Figure 6. Global ChP Sales YoY Growth (2021-2032) & (MT) Figure 7. USP Image Figure 8. Global USP Sales YoY Growth (2021-2032) & (MT) Figure 9. EP Image Figure 10. Global EP Sales YoY Growth (2021-2032) & (MT) Figure 11. Global Cefotaxime Sodium API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cefotaxime Sodium API Market Share by Type 2025 VS 2032 Figure 13. North America Cefotaxime Sodium API Sales Market Share in Volume by Type in 2025 Figure 14. North America Cefotaxime Sodium API Sales Market Share in Value by Type in 2025 Figure 15. Europe Cefotaxime Sodium API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cefotaxime Sodium API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cefotaxime Sodium API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cefotaxime Sodium API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cefotaxime Sodium API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cefotaxime Sodium API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cefotaxime Sodium API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cefotaxime Sodium API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cefotaxime Sodium API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Single Injection Image Figure 26. Global Single Injection Sales YoY Growth (2021-2032) & (MT) Figure 27. Compound Injection Image Figure 28. Global Compound Injection Sales YoY Growth (2021-2032) & (MT) Figure 29. Global Cefotaxime Sodium API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cefotaxime Sodium API Market Share by Application 2025 VS 2032 Figure 31. North America Cefotaxime Sodium API Sales Market Share in Volume by Application in 2025 Figure 32. North America Cefotaxime Sodium API Sales Market Share in Value by Application in 2025 Figure 33. Europe Cefotaxime Sodium API Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cefotaxime Sodium API Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cefotaxime Sodium API Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cefotaxime Sodium API Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cefotaxime Sodium API Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cefotaxime Sodium API Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cefotaxime Sodium API Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cefotaxime Sodium API Sales Market Share in Value by Application in 2025 Figure 41. North America Cefotaxime Sodium API Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 42. North America Cefotaxime Sodium API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cefotaxime Sodium API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cefotaxime Sodium API Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cefotaxime Sodium API Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 46. Europe Cefotaxime Sodium API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cefotaxime Sodium API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cefotaxime Sodium API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cefotaxime Sodium API Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 50. Asia-Pacific Cefotaxime Sodium API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cefotaxime Sodium API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cefotaxime Sodium API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cefotaxime Sodium API Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 54. Latin America Cefotaxime Sodium API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cefotaxime Sodium API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cefotaxime Sodium API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cefotaxime Sodium API Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 58. Middle East and Africa Cefotaxime Sodium API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cefotaxime Sodium API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cefotaxime Sodium API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cefotaxime Sodium API Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cefotaxime Sodium API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • ChP
  • USP
  • EP
Applications
  • Single Injection
  • Compound Injection
Companies covered
  • REYOUNG
  • Nectar Lifesciences
  • Medya Pharma
  • Sandoz
  • Kelun
  • NCPC
  • Aurobindo Pharma
  • United Laboratories
  • Orchid Pharma
  • CSPC
  • Kopran
  • Covalent
  • ACS Dobfar
  • Dawnrays
  • Sterile India

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cefotaxime Sodium API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cefotaxime Sodium API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cefotaxime Sodium API Market by Type
  6. 1.3.1 ChP
  7. 1.3.2 USP
  8. 1.3.3 EP
  9. 1.4 Global Cefotaxime Sodium API Market Size by Type
  10. 1.4.1 Global Cefotaxime Sodium API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cefotaxime Sodium API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cefotaxime Sodium API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cefotaxime Sodium API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cefotaxime Sodium API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cefotaxime Sodium API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cefotaxime Sodium API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cefotaxime Sodium API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cefotaxime Sodium API Industry Trends
  2. 2.2 Cefotaxime Sodium API Industry Drivers
  3. 2.3 Cefotaxime Sodium API Industry Opportunities and Challenges
  4. 2.4 Cefotaxime Sodium API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cefotaxime Sodium API Revenue (2021-2026)
  2. 3.2 Global Top Players by Cefotaxime Sodium API Sales (2021-2026)
  3. 3.3 Global Top Players by Cefotaxime Sodium API Price (2021-2026)
  4. 3.4 Global Cefotaxime Sodium API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cefotaxime Sodium API Major Company Production Sites & Headquarters
  6. 3.6 Global Cefotaxime Sodium API Company, Product Type & Application
  7. 3.7 Global Cefotaxime Sodium API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cefotaxime Sodium API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cefotaxime Sodium API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cefotaxime Sodium API Tier 1, Tier 2, and Tier 3
4 Cefotaxime Sodium API Regional Status and Outlook
  1. 4.1 Global Cefotaxime Sodium API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cefotaxime Sodium API Historic Market Size by Region
  3. 4.2.1 Global Cefotaxime Sodium API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cefotaxime Sodium API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cefotaxime Sodium API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cefotaxime Sodium API Forecasted Market Size by Region
  7. 4.3.1 Global Cefotaxime Sodium API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cefotaxime Sodium API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cefotaxime Sodium API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cefotaxime Sodium API by Application
  1. 5.1 Cefotaxime Sodium API Market by Application
  2. 5.1.1 Single Injection
  3. 5.1.2 Compound Injection
  4. 5.2 Global Cefotaxime Sodium API Market Size by Application
  5. 5.2.1 Global Cefotaxime Sodium API Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cefotaxime Sodium API Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cefotaxime Sodium API Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cefotaxime Sodium API Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cefotaxime Sodium API Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cefotaxime Sodium API Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cefotaxime Sodium API Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cefotaxime Sodium API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 REYOUNG
  2. 6.1.1 REYOUNG Company Information
  3. 6.1.2 REYOUNG Business Overview
  4. 6.1.3 REYOUNG Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 REYOUNG Cefotaxime Sodium API Product Portfolio
  6. 6.1.5 REYOUNG Recent Developments
  7. 6.2 Nectar Lifesciences
  8. 6.2.1 Nectar Lifesciences Company Information
  9. 6.2.2 Nectar Lifesciences Business Overview
  10. 6.2.3 Nectar Lifesciences Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nectar Lifesciences Cefotaxime Sodium API Product Portfolio
  12. 6.2.5 Nectar Lifesciences Recent Developments
  13. 6.3 Medya Pharma
  14. 6.3.1 Medya Pharma Company Information
  15. 6.3.2 Medya Pharma Business Overview
  16. 6.3.3 Medya Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Medya Pharma Cefotaxime Sodium API Product Portfolio
  18. 6.3.5 Medya Pharma Recent Developments
  19. 6.4 Sandoz
  20. 6.4.1 Sandoz Company Information
  21. 6.4.2 Sandoz Business Overview
  22. 6.4.3 Sandoz Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sandoz Cefotaxime Sodium API Product Portfolio
  24. 6.4.5 Sandoz Recent Developments
  25. 6.5 Kelun
  26. 6.5.1 Kelun Company Information
  27. 6.5.2 Kelun Business Overview
  28. 6.5.3 Kelun Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kelun Cefotaxime Sodium API Product Portfolio
  30. 6.5.5 Kelun Recent Developments
  31. 6.6 NCPC
  32. 6.6.1 NCPC Company Information
  33. 6.6.2 NCPC Business Overview
  34. 6.6.3 NCPC Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NCPC Cefotaxime Sodium API Product Portfolio
  36. 6.6.5 NCPC Recent Developments
  37. 6.7 Aurobindo Pharma
  38. 6.7.1 Aurobindo Pharma Company Information
  39. 6.7.2 Aurobindo Pharma Business Overview
  40. 6.7.3 Aurobindo Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aurobindo Pharma Cefotaxime Sodium API Product Portfolio
  42. 6.7.5 Aurobindo Pharma Recent Developments
  43. 6.8 United Laboratories
  44. 6.8.1 United Laboratories Company Information
  45. 6.8.2 United Laboratories Business Overview
  46. 6.8.3 United Laboratories Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 United Laboratories Cefotaxime Sodium API Product Portfolio
  48. 6.8.5 United Laboratories Recent Developments
  49. 6.9 Orchid Pharma
  50. 6.9.1 Orchid Pharma Company Information
  51. 6.9.2 Orchid Pharma Business Overview
  52. 6.9.3 Orchid Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Orchid Pharma Cefotaxime Sodium API Product Portfolio
  54. 6.9.5 Orchid Pharma Recent Developments
  55. 6.10 CSPC
  56. 6.10.1 CSPC Company Information
  57. 6.10.2 CSPC Business Overview
  58. 6.10.3 CSPC Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CSPC Cefotaxime Sodium API Product Portfolio
  60. 6.10.5 CSPC Recent Developments
  61. 6.11 Kopran
  62. 6.11.1 Kopran Company Information
  63. 6.11.2 Kopran Business Overview
  64. 6.11.3 Kopran Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Kopran Cefotaxime Sodium API Product Portfolio
  66. 6.11.5 Kopran Recent Developments
  67. 6.12 Covalent
  68. 6.12.1 Covalent Company Information
  69. 6.12.2 Covalent Business Overview
  70. 6.12.3 Covalent Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Covalent Cefotaxime Sodium API Product Portfolio
  72. 6.12.5 Covalent Recent Developments
  73. 6.13 ACS Dobfar
  74. 6.13.1 ACS Dobfar Company Information
  75. 6.13.2 ACS Dobfar Business Overview
  76. 6.13.3 ACS Dobfar Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 ACS Dobfar Cefotaxime Sodium API Product Portfolio
  78. 6.13.5 ACS Dobfar Recent Developments
  79. 6.14 Dawnrays
  80. 6.14.1 Dawnrays Company Information
  81. 6.14.2 Dawnrays Business Overview
  82. 6.14.3 Dawnrays Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Dawnrays Cefotaxime Sodium API Product Portfolio
  84. 6.14.5 Dawnrays Recent Developments
  85. 6.15 Sterile India
  86. 6.15.1 Sterile India Company Information
  87. 6.15.2 Sterile India Business Overview
  88. 6.15.3 Sterile India Cefotaxime Sodium API Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sterile India Cefotaxime Sodium API Product Portfolio
  90. 6.15.5 Sterile India Recent Developments
7 North America by Country
  1. 7.1 North America Cefotaxime Sodium API Sales by Country
  2. 7.1.1 North America Cefotaxime Sodium API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cefotaxime Sodium API Sales by Country (2021-2026)
  4. 7.1.3 North America Cefotaxime Sodium API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cefotaxime Sodium API Market Size by Country
  6. 7.2.1 North America Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cefotaxime Sodium API Market Size by Country (2021-2026)
  8. 7.2.3 North America Cefotaxime Sodium API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cefotaxime Sodium API Sales by Country
  2. 8.1.1 Europe Cefotaxime Sodium API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cefotaxime Sodium API Sales by Country (2021-2026)
  4. 8.1.3 Europe Cefotaxime Sodium API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cefotaxime Sodium API Market Size by Country
  6. 8.2.1 Europe Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cefotaxime Sodium API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cefotaxime Sodium API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cefotaxime Sodium API Sales by Country
  2. 9.1.1 Asia-Pacific Cefotaxime Sodium API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cefotaxime Sodium API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cefotaxime Sodium API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cefotaxime Sodium API Market Size by Country
  6. 9.2.1 Asia-Pacific Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cefotaxime Sodium API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cefotaxime Sodium API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cefotaxime Sodium API Sales by Country
  2. 10.1.1 South America Cefotaxime Sodium API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cefotaxime Sodium API Sales by Country (2021-2026)
  4. 10.1.3 South America Cefotaxime Sodium API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cefotaxime Sodium API Market Size by Country
  6. 10.2.1 South America Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cefotaxime Sodium API Market Size by Country (2021-2026)
  8. 10.2.3 South America Cefotaxime Sodium API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cefotaxime Sodium API Sales by Country
  2. 11.1.1 Middle East and Africa Cefotaxime Sodium API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cefotaxime Sodium API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cefotaxime Sodium API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cefotaxime Sodium API Market Size by Country
  6. 11.2.1 Middle East and Africa Cefotaxime Sodium API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cefotaxime Sodium API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cefotaxime Sodium API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cefotaxime Sodium API Value Chain Analysis
  2. 12.1.1 Cefotaxime Sodium API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cefotaxime Sodium API Production Mode & Process
  7. 12.2 Cefotaxime Sodium API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cefotaxime Sodium API Distributors
  10. 12.2.3 Cefotaxime Sodium API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst